Approach to neck lump thyroid lumps and cancers

  • Slides: 26
Download presentation
Approach to neck lump, thyroid lumps and cancers, and parathyroid disorders MRCS teaching 01

Approach to neck lump, thyroid lumps and cancers, and parathyroid disorders MRCS teaching 01 September 2015

Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Clinical Anatomy: Applied Anatomy for Students and Junior Doctors by Ellis and Mahadevan

Clinical Anatomy: Applied Anatomy for Students and Junior Doctors by Ellis and Mahadevan

Clinical Anatomy: Applied Anatomy for Students and Junior Doctors by Ellis and Mahadevan

Clinical Anatomy: Applied Anatomy for Students and Junior Doctors by Ellis and Mahadevan

Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Differential diagnosis • Congenital, inflammatory, neoplastic • 2 -9% of head and neck cancers

Differential diagnosis • Congenital, inflammatory, neoplastic • 2 -9% of head and neck cancers present as cervical masses without a known primary • Up to 80% of neck masses that occur outside thyroid are neoplastic in adults over age of 40 years Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

History Age Personal or family history of malignancy Smoking/tobacco use or heavy alcohol Sun

History Age Personal or family history of malignancy Smoking/tobacco use or heavy alcohol Sun and radiation exposure Persistent mass, dysphagia, hoarseness, neurologic deficit, epistaxis, radiating pain • Constitutional symptoms • Rapidly developing tender masses are often infectious/inflammatory • Prior treatment/surgery • • • Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Surgery At A Glance, Fifth Edition, by Pierce and Niel

Surgery At A Glance, Fifth Edition, by Pierce and Niel

Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Imaging • Chest X-ray/CT thorax • Ultrasound scan – Hyper or hypoechogenicity, cystic degeneration,

Imaging • Chest X-ray/CT thorax • Ultrasound scan – Hyper or hypoechogenicity, cystic degeneration, punctuate calcifications, unclear borders with surrounding structures perinodal oedema • CT scan – Invasion or distortion of normal anatomy – If thought to be nodal metastasis, can identify primary source in 20% • MRI – Presence of invasion into surrounding structures especially vascular or neural structures • PET – Not first-line – Metastatic squamous cell carcinoma of unknown primary – Further workup for known diagnosis Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Tissue diagnosis • • FNA Core biopsy Excision biopsy Panendoscopy and biopsy – Laryngoscopy,

Tissue diagnosis • • FNA Core biopsy Excision biopsy Panendoscopy and biopsy – Laryngoscopy, bronchoscopy and esophagoscopy – Biopsy – Tonsillectomy (tonsils are found to be the primary source in 20 -40% of these patients) Current Surgical Therapy: Evaluation of the isolated neck mass by Philip, Smith et al

Thyroid

Thyroid

Work-up • • Thyroid function test Serum Tg (not initial evaluation) Calcitonin (if suspect

Work-up • • Thyroid function test Serum Tg (not initial evaluation) Calcitonin (if suspect MTC) Ultrasound – Ill-defined borders, microcalcifications, internal vascularity, absence of colloid halo sign, hypoechogenicity, suspicious lymph nodes • • FNA Radionuclide thyroid scan (if TSH subnormal) CT/MR neck/PET Nasopharyngolaryngoscopy Current Surgical Therapy: Management of Thyroid Nodules Cooper, David S, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 19. 11 (2009): 1167 -1214.

National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 2. 2013

National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 2. 2013

Current Surgical Therapy: Management of Thyroid Nodules

Current Surgical Therapy: Management of Thyroid Nodules

Thyroid carcinoma • • • Papillary thyroid cancer Follicular cancer Hürthle cell cancer Anaplastic

Thyroid carcinoma • • • Papillary thyroid cancer Follicular cancer Hürthle cell cancer Anaplastic cancer Medullary thyroid cancer Lymphoma

Thyroid carcinoma • Papillary thyroid cancer (80%) – Young, irradiation, FAP, Gardner’s syndrome, Cowden

Thyroid carcinoma • Papillary thyroid cancer (80%) – Young, irradiation, FAP, Gardner’s syndrome, Cowden disease, Wegener’s syndrome – Lymph node spread – Total thyroidectomy + neck dissection if any of: • age <15 or >45, radiation history, known distant metastasi, bilateral nodularity, tumour >4 cm, cervical LN metastasis, aggressive variant – Completion total thyroidectomy if • Tumour >4 cm, positive margins, gross extrathyroidal extension, macroscopic multifocal disease, confirmed nodal metastasis, vascular invasion – RAI – Surveillance with TSH, Tg, antithyroglobulin Ab and US National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 2. 2013 Cooper, David S, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 19. 11 (2009): 1167 -1214.

Thyroid carcinoma • Follicular cancer (10%) and Hürthle cell cancer – Middle age –

Thyroid carcinoma • Follicular cancer (10%) and Hürthle cell cancer – Middle age – Blood spread – Total thyroidectomy if invasive cancer, metastatic cancer or patient preference • Central neck dissection if lymph node positive • Lateral neck dissection if clinically involved – Completion thyroidectomy if invasive cancer – RAI – Surveillance with TSH, Tg, antithyroglobulin Ab and US National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 2. 2013

Thyroid carcinoma • Medullary thyroid cancer – MEN 2 – Serum calcium, calcitonin, CEA,

Thyroid carcinoma • Medullary thyroid cancer – MEN 2 – Serum calcium, calcitonin, CEA, pheochromocytoma screen, RET proto-oncogene – Total thyroidectomy + central neck dissection ± lateral neck dissection – Adjuvant EBRT • Anaplastic cancer – 10 year <1%, poor prognosis – FBC, calcium, TSH, CT/PET – Local disease: total thyroidectomy and selective resection of local/regional structures and lymph nodes – EBRT, chemotherapy, best supportive care National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma Version 2. 2013

Parathyroid

Parathyroid

Primary hyperparathyroidism • • Most common cause for hypercalcaemia Excessive PTH production Incidence 1%,

Primary hyperparathyroidism • • Most common cause for hypercalcaemia Excessive PTH production Incidence 1%, 2% after age 55 Women 2 -3 times more likely Single adenoma in 80 -85% Parathyroid carcinoma in 1% Present in nearly all patients with MEN 1 and 25% in MEN 2 A Current Surgical Therapy: Primary Hyperparathyroidism

Work-up • • • High or high-normal calcium Elevated or high normal (nonsuppressed) PTH

Work-up • • • High or high-normal calcium Elevated or high normal (nonsuppressed) PTH Decreased serum phosphate Increased or high-normal chloride 24 -hour urinary calcium and creatinine – To rule out familial hypercalcemia hypocalciuria • Sestamibi scan • US neck Current Surgical Therapy: Primary Hyperparathyroidism

Indications for surgery • Symptomatic • Younger than 50 years old • Serum calcium

Indications for surgery • Symptomatic • Younger than 50 years old • Serum calcium levels over 1 mg/d. L above upper limit of normal (2. 8 mmol/L) • Creatinine clearance less than 60 m. L/min • Bone mineral density T score ≤ 2. 5 Current Surgical Therapy: Primary Hyperparathyroidism

Treatment • Minimally invasive parathyroidectomy with intraoperative parathyroid hormone monitoring – 50% drop in

Treatment • Minimally invasive parathyroidectomy with intraoperative parathyroid hormone monitoring – 50% drop in the intact parathyroid hormone level – Complication rate 1% • Bilateral neck exploration – Procedure of choice for MEN – Trachea-oesophageal groove, thymus, within thyroid, carotid sheath – Complication rate (including RLN injury) 4% Current Surgical Therapy: Primary Hyperparathyroidism